Mount Baiyun (00874) is planning to participate in the establishment of GYGGF and GYLGCF.

The Zhongtong Financial APP announced that Baiyun Mountain (00874) disclosed on December 22, 2025, that the board of directors approved the establishment of Guangzhou Baiyunshan Pharmaceutical Group's subsidiary Guangzhou Pharmaceutical Phase II Fund, Guangzhou Pharmaceutical Capital, and Guangzhou Development Fund. Partnership agreement. According to this, Guangzhou Baiyunshan Pharmaceutical Phase II Fund, Guangzhou Pharmaceutical Capital, and Guangzhou Development Fund respectively invested 97.5 million yuan, 2.5 million yuan, and 100 million yuan to participate in the establishment of Guangzhou Baiyunshan Pharmaceutical Group.